Search Results 101-110 of 2481 for 2024embarking
All users should check our website before requesting samples to confirm that their experimental plans are well suited for these PDX lines.
Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...
Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.
The goal is to prove feasibility as well as safety of this approach. We will test adaptive therapy in 35 metastatic breast cancer patients diagnosed with ER+ ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
placebo with azacitidine (AZA) as background therapy in patients ≥ 18 years of age with newly diagnosed acute myeloid leukemia (AML), excluding acute ...
What is this event about each year? Richard Zimmerman, M.D., dean for education at Mayo Clinic College of Medicine and Science in Arizona, summed it up in ...
The primary hypothesis of this study is that overall survival (OS) and/or progression-free survival (PFS) is prolonged in participants who receive pembrolizumab ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.